Agilent Technologies Debt to Equity Ratio 2006-2018 | A

Current and historical debt to equity ratio values for Agilent Technologies (A) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Agilent Technologies debt/equity for the three months ending July 31, 2018 was 0.39.
Agilent Technologies Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-07-31 $1.80B $4.57B 0.39
2018-04-30 $1.80B $4.62B 0.39
2018-01-31 $1.80B $4.53B 0.40
2017-10-31 $1.80B $4.84B 0.37
2017-07-31 $1.80B $4.61B 0.39
2017-04-30 $1.80B $4.38B 0.41
2017-01-31 $1.80B $4.30B 0.42
2016-10-31 $1.90B $4.25B 0.45
2016-07-31 $1.65B $4.35B 0.38
2016-04-30 $1.65B $4.17B 0.40
2016-01-31 $1.65B $4.05B 0.41
2015-10-31 $1.66B $4.17B 0.40
2015-07-31 $1.66B $4.11B 0.40
2015-04-30 $1.66B $4.16B 0.40
2015-01-31 $1.66B $4.24B 0.39
2014-10-31 $1.66B $5.30B 0.31
2014-07-31 $2.18B $5.64B 0.39
2014-04-30 $2.69B $5.63B 0.48
2014-01-31 $2.70B $5.45B 0.50
2013-10-31 $2.70B $5.29B 0.51
2013-07-31 $2.70B $4.79B 0.56
2013-04-30 $2.11B $5.31B 0.40
2013-01-31 $2.11B $5.35B 0.40
2012-10-31 $2.11B $5.19B 0.41
2012-07-31 $1.71B $4.87B 0.35
2012-04-30 $1.93B $4.73B 0.41
2012-01-31 $1.93B $4.50B 0.43
2011-10-31 $1.93B $4.32B 0.45
2011-07-31 $2.17B $4.20B 0.52
2011-04-30 $2.14B $3.96B 0.54
2011-01-31 $2.14B $3.34B 0.64
2010-10-31 $2.19B $3.24B 0.68
2010-07-31 $2.18B $2.81B 0.78
2010-04-30 $1.39B $2.63B 0.53
2010-01-31 $1.41B $2.60B 0.54
2009-10-31 $2.90B $2.51B 1.16
2009-07-31 $2.15B $2.49B 0.87
2009-04-30 $2.15B $2.42B 0.89
2009-01-31 $2.15B $2.57B 0.84
2008-10-31 $2.13B $2.56B 0.83
2008-07-31 $0.60B $3.19B 0.19
2008-04-30 $0.62B $3.16B 0.20
2008-01-31 $0.63B $3.17B 0.20
2007-10-31 $2.09B $3.23B 0.65
2007-07-31 $1.50B $3.29B 0.46
2007-04-30 $1.50B $3.56B 0.42
2007-01-31 $1.50B $3.66B 0.41
2006-10-31 $1.50B $3.65B 0.41
2006-07-31 $1.50B $3.79B 0.40
2006-04-30 $1.50B $4.07B 0.37
2006-01-31 $1.50B $4.18B 0.36
2005-10-31 $0.00B $4.08B 0.00
2005-07-31 $1.15B $3.95B 0.29
2005-04-30 $1.15B $3.87B 0.30
2005-01-31 $1.15B $3.77B 0.31
Sector Industry Market Cap Revenue
Computer and Technology Electrical Test Equipment $19.958B $4.914B
Agilent Technologies Inc. focuses its expertise on six key markets: Food; Environmental and Forensics; Pharmaceutical; Diagnostics; Chemical and Energy; and Research. Agilent helps ensure that their global food supply is free of contaminants, whether chemical, viral, bacterial or microbiological. The Company's customers include government regulators and labs that control food safety, as well as private companies that produce, package and sell food to the public. Agilent has one of the broadest solutions portfolios of any company serving the pharmaceutical industry. Its solutions provide precise answers for every segment of the pharmaceutical industry, from disease research and drug discovery to drug development, manufacturing and quality control. Agilent gives doctors a head start in the fight against cancer and other diseases. Agilent's immunohistochemistry (IHC) products provide high staining quality, improved standardization and increased efficiency enabling the ultimate goal of increased patient safety.
Stock Name Country Market Cap PE Ratio
Fortive (FTV) United States $24.633B 21.89
AMETEK (AME) United States $16.852B 23.19
Cognex (CGNX) United States $7.010B 31.81
National Instruments (NATI) United States $6.358B 38.72
Teradyne (TER) United States $6.326B 15.97
Itron (ITRI) United States $2.076B 18.95